Medical
Piper Sandler Reaffirms Tango Therapeutics’ Stock Overweight Rating Amid Drug Pipeline Developments
Tango Therapeutics Stock : Analyst Confidence Stays Strong Piper Sandler has reaffirmed its Overweight rating for Tango Therapeutics Inc stock(NASDAQ: TNGX). The price target remains...
Positive Interim Data Drives Centessa Pharmaceuticals’ Stock Surge
Positive Trial Data Propels Centessa Shares Higher – Centessa Pharmaceuticals plc (NASDAQ: CNTA) is gaining attention in the stock market with its recent press release....
SINTX Technologies Shares Surge 91% on Patent Approval, Then Correct; What’s Next for Investors?
Patent Approval Sparks SINTX Technologies Shares Surge SINTX Technologies Inc (SINT) saw a dramatic 91.5% surge in its shares price to $5.40 on Monday. However,...
PainReform Ltd Announces Warrant Exercise Amid Stock Decline
PainReform Announces Warrant Exercise PainReform Ltd. (Nasdaq: PRFX) has unveiled a significant development. The clinical-stage pharmaceutical company has entered into definitive agreements for the immediate...
Alimera Sciences Shares Plunge 20% Amid Lawsuit Against ANI Pharmaceuticals Merger
Alimera Sciences Shares Drop After Merger Lawsuit Alimera Sciences saw its shares drop significantly on Tuesday. The company announced a lawsuit against ANI Pharmaceuticals, aiming...
Butterfly Network Soars as Fierce 50 Honoree Amidst Stock Surge
Butterfly Network Makes Waves in Healthcare Innovation Butterfly Network, Inc (NYSE: BFLY), a leader in portable ultrasound technology, has achieved a significant milestone. The company...
Tango Therapeutics Stock Slides Despite Strong Analyst Ratings and Positive Earnings
Market Slump for Tango Therapeutics Stock The stock of Tango Therapeutics (NASDAQ: TNGX) experienced a significant decline before the market opened on Monday. Tango Therapeutics...
TC BioPharm Announces Preclinical Studies for Monkeypox Treatment
TC BioPharm Announces Preclinical Studies for TCB008 TC BioPharm, a biotechnology company specializing in gamma-delta T cell therapies, has announced its plans to initiate preclinical...
Oragenics Faces Decline as Stock Offering Hits Market
Oragenics Announces Stock Offering Oragenics, Inc (NYSE American: OGEN) has announced a new stock offering. The company will issue 8,106,584 shares of common stock at...
Recursion Pharmaceuticals Plunges 15% After Mixed Phase 2 Trial Results for CCM Treatment
Recursion Pharmaceuticals Faces Market Backlash After Phase 2 Trial Results Update Shares of Recursion Pharmaceuticals (NASDAQ: RXRX) fell sharply on Tuesday, after the company released...
